|
|
Volumn 336, Issue 13, 1997, Pages 952-953
|
|
Strategies for the treatment of sepsis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BACTERIUM LIPOPOLYSACCHARIDE;
BINDING PROTEIN;
CD14 ANTIGEN;
IBUPROFEN;
IMMUNOGLOBULIN M ANTIBODY;
INTERLEUKIN 1;
LACTIC ACID;
LIPID A;
MONOCLONAL ANTIBODY;
PROSTAGLANDIN SYNTHASE INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
BODY TEMPERATURE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEART RATE;
HOST RESISTANCE;
HUMAN;
INFLAMMATION;
INTRAVENOUS DRUG ADMINISTRATION;
LACTIC ACIDOSIS;
MORTALITY;
MULTIPLE ORGAN FAILURE;
NONHUMAN;
OXYGEN CONSUMPTION;
PRIORITY JOURNAL;
SEPSIS;
HUMANS;
IBUPROFEN;
SEPSIS;
|
|
EID: 0030910681
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199703273361311 Document Type: Editorial |
|
Times cited : (100)
|
|
References (9)
|
